BioCatalystWatch
RNAZWorkspace / RNAZ / OverviewCompany library
Transcode Therapeutics, Inc. logo

Transcode Therapeutics, Inc.

Transcode Therapeutics, Inc. (RNAZ)

Website

Price
Market cap
Next catalystExpected 1H 2027TTX-MC138 — PRE-I-SPY colorectal MRD cohort · Trial initiationSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

Seviprotimut-L

Vaccine

Polyvalent shed antigens

PreINDP1P2P3FilingApproved

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Seviprotimut-L

Vaccine

Polyvalent shed antigens

PreINDP1P2P3FilingApproved

Other pipelines

TTX-MC138

Antisense oligonucleotide

miR-10b

PreINDP1P2P3FilingApproved
TTX-MC138

Antisense oligonucleotide

miR-10b

TTX-MC138

Antisense oligonucleotide

miR-10b

TTX-MC138

Antisense oligonucleotide

miR-10b

TTX-siPDL1

PD-L1

PreINDP1P2P3FilingApproved
UIO-524

Oncolytic virus

DSG2

PreINDP1P2P3FilingApproved

Partner / License out

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

RNAZ PR & News

PR & News

RNAZ SEC archive